Cascades Inc. Set to Release Q4 and Full Year 2024 Results: What Investors Need to Know

As Cascades Inc. (TSX: CAS) prepares to release its fourth quarter and full year 2024 financial results on February 20, 2025, investors are eager to understand the company's performance and strategic direction. With a focus on sustainable packaging, hygiene, and recovery solutions, Cascades has been navigating market challenges and implementing strategic initiatives to drive growth and profitability. Here's what investors need to know ahead of the earnings release.

1. Key Financial Indicators to Watch: Investors should pay close attention to the following key financial indicators when analyzing Cascades' Q4 and full-year 2024 results:
* Sales and revenue growth: Investors should examine the year-over-year (YoY) change in sales and revenue to assess the company's top-line growth. In Q3 2024, Cascades reported sales of $1,201 million, up from $1,198 million in Q3 2023. For the full year, investors should compare the 2024 sales with the 2023 sales to gauge the company's overall revenue growth.
* Operating income and net earnings: These metrics provide insights into the company's profitability. In Q3 2024, Cascades reported operating income of $36 million and net earnings per common share of $0.01. Comparing these figures with the previous year's results will help investors understand the company's earnings trend.
* Adjusted EBITDA: This metric excludes non-cash and non-recurring items, providing a more accurate picture of the company's operating performance. In Q3 2024, Cascades' adjusted EBITDA was $140 million, compared to $161 million in Q3 2023. Investors should analyze the YoY change in adjusted EBITDA to assess the company's operational efficiency.
* Net debt and net debt to EBITDA ratio: These metrics help investors evaluate the company's financial health and liquidity. In Q3 2024, Cascades' net debt was $2,039 million, and the net debt to EBITDA ratio was 4.3x. Investors should monitor these metrics to ensure the company maintains a healthy balance between debt and earnings.
* Capital expenditures (CapEx): CapEx indicates the company's investment in maintaining and expanding its operations. In Q3 2024, Cascades' total capital expenditures, net of disposals, were $34 million. Investors should analyze the company's CapEx trends to understand its long-term growth prospects.
* Segment performance: Investors should review the performance of each segment (Containerboard, Specialty Products, and Tissue Papers) to identify trends and opportunities. In Q3 2024, the Containerboard segment showed improvement, while Tissue Papers faced declines due to higher raw material costs and adjustments in product mix.
2. Strategic Initiatives: Cascades' strategic initiatives, such as the expansion of the Bear Island facility and the installation of new tissue converting lines, have had a positive impact on the company's financial performance. These initiatives aim to drive cash flow growth and reduce debt, aligning with the company's long-term vision for shareholder value enhancement. Investors should assess the progress and results of these strategic initiatives in the upcoming earnings release.
3. Organizational Changes: In October 2024, Cascades announced organizational changes designed to support the company's strategic growth by strengthening alignment, increasing agility, and enhancing operational efficiency. These changes are expected to have potential implications for the company's future growth and profitability. Investors should evaluate the impact of these organizational changes on the company's performance and strategic direction.



In conclusion, investors should focus on the key financial indicators, strategic initiatives, and organizational changes when analyzing Cascades' Q4 and full-year 2024 results. By understanding the company's performance and strategic direction, investors can make informed decisions about the company's future prospects and potential investment opportunities.